American Portfolios Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.39M Buy
22,488
+15,148
+206% +$955K 0.06% 328
2022
Q2
$454K Sell
7,340
-1,712
-19% -$106K 0.02% 706
2022
Q1
$538K Sell
9,052
-386
-4% -$24.7K 0.02% 703
2021
Q4
$685K Buy
9,438
+563
+6% +$38.8K 0.02% 613
2021
Q3
$620K Sell
8,875
-295
-3% -$20.7K 0.02% 618
2021
Q2
$631K Sell
9,170
-1,324
-13% -$88.4K 0.02% 616
2021
Q1
$678K Buy
10,494
+1,123
+12% +$72.4K 0.03% 544
2020
Q4
$546K Sell
9,371
-3,059
-25% -$185K 0.03% 536
2020
Q3
$785K Sell
12,430
-10,549
-46% -$732K 0.05% 357
2020
Q2
$1.77M Sell
22,979
-5,600
-20% -$429K 0.12% 178
2020
Q1
$2.14M Buy
28,579
+14,803
+107% +$1.02M 0.18% 129
2019
Q4
$895K Sell
13,776
-1,347
-9% -$87.7K 0.06% 290
2019
Q3
$958K Sell
15,123
-601
-4% -$39.3K 0.08% 246
2019
Q2
$1.06M Buy
15,724
+1,746
+12% +$115K 0.09% 225
2019
Q1
$909K Buy
13,978
+837
+6% +$55.6K 0.09% 231
2018
Q4
$822K Sell
13,141
-3,121
-19% -$218K 0.1% 201
2018
Q3
$1.26M Sell
16,262
-514
-3% -$38.8K 0.14% 144
2018
Q2
$1.19M Buy
16,776
+838
+5% +$59.2K 0.16% 125
2018
Q1
$1.2M Buy
15,938
+973
+7% +$77.3K 0.18% 119
2017
Q4
$1.07M Buy
+14,965
New +$1.14M 0.17% 134

Other funds holding GILD

American Portfolios Advisors's GILD Position: Q3 2022 in Review

American Portfolios Advisors increased its Gilead Sciences (GILD) stake by 206% in Q3 2022, buying an estimated $955K and bringing the position to 22,488 shares worth $1.39M. The position accounts for 0.06% of the portfolio, ranked #328.

American Portfolios Advisors first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.14M in Q1 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • American Portfolios Advisors held 22,488 shares of Gilead Sciences worth $1.39M as of Q3 2022.
  • American Portfolios Advisors bought 15,148 Gilead Sciences shares in Q3 2022, an estimated $955K.
  • Gilead Sciences made up 0.06% of American Portfolios Advisors's portfolio in Q3 2022, its #328 holding.
  • American Portfolios Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Gilead Sciences position peaked at $2.14M in Q1 2020.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.